Psychosocial Factors and Disease Activity in Multiple Sclerosis

Multiple sclerosis (MS) is a complex neuroinflammatory disorder in which psychosocial factors—encompassing stress, mood disturbances, social support and coping strategies—interact with immune pathways to influence disease course. Chronic stress and adverse experiences can dysregulate the hypothalamic–pituitary–adrenal axis and increase allostatic load, leading to pro-inflammatory shifts that may exacerbate demyelination and neurodegeneration. Mood disorders such as depression and anxiety are highly prevalent in people with MS, and bidirectional psycho-neuro-immune mechanisms underpin the links between emotional distress and relapse activity. Protective factors, including effective coping styles, social network engagement and interventions that enhance top-down regulation of limbic circuitry, offer pathways to mitigate inflammatory activity, preserve cognitive function and improve quality of life. Taken together, this body of work highlights the necessity of integrating psychosocial assessment and tailored behavioural therapies into comprehensive MS management to address both neurological and systemic dimensions of disease activity.

Research from Nature Portfolio

Recent studies have investigated how behavioural interventions and early-life stressors converge on immune regulation in MS. A pilot investigation of a mindfulness-based stress reduction programme demonstrated that structured meditation and cognitive training in people with MS were associated with improvements in anxiety, depression and perceived stress, accompanied by enlargement of the hippocampal head and reductions in peripheral transcripts related to inflammatory signalling. These findings suggest that top-down modulation of limbic circuits can attenuate systemic inflammatory profiles linked to relapse risk. Complementary mechanistic work in an experimental autoimmune encephalomyelitis model revealed that exposure to early-life trauma induces chronic downregulation of β1-adrenergic receptors on immune cells, driving interferon-β resistance and neurodegenerative changes. Restoration of adrenergic signalling in this context reversed immune dysfunction, underscoring the lasting impact of developmental stress on neuroimmune crosstalk and MS heterogeneity.

Psychosocial Factors and Disease Activity in Multiple Sclerosis publication trend

The graph below shows the total number of articles in psychosocial factors and disease activity in multiple sclerosis across all publications each year (not limited to Nature Index journals).

Technical terms

Allostatic load: Cumulative physiological wear and tear resulting from chronic activation of stress-response systems.

Adverse childhood experiences (ACEs): Potentially traumatic events in early life, such as abuse or neglect, that can alter lifelong stress and immune regulation.

Mindfulness-based stress reduction (MBSR): A structured programme of meditation, body awareness and cognitive exercises designed to improve stress management and emotional regulation.

Interferon-β resistance: A diminished cellular response to therapeutic or endogenous interferon-β, impairing anti-inflammatory signalling in MS.

References

1. A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis. Scientific Reports (2024).
2. Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling. Nature Communications (2021).
3. Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms. International Journal of Molecular Sciences (2024).
4. A new framework for understanding stress and disease: the developmental model of stress as applied to multiple sclerosis. Frontiers in Integrative Neuroscience (2024).
5. Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic. Neurological Sciences (2022).